Abstract
Objective In the UK there are around 5400 deaths annually from injury. Tranexamic acid (TXA) prevents bleeding and has been shown to reduce trauma mortality. However, only 5% of UK major trauma patients who are at risk of haemorrhage receive prehospital TXA. This review aims to examine the evidence regarding factors influencing the prehospital administration of TXA to trauma patients.
Reference:
Nicholson H, Scotney N, Briscoe S, et al Factors that influence the administration of tranexamic acid (TXA) to trauma patients in prehospital settings: a systematic review. BMJ Open 2023;13:e073075. doi: 10.1136/bmjopen-2023-073075